Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Number of holders
-
44
-
Total 13F principal, excl. options
-
405,389,800
-
Principal change
-
+53,283,716
-
Total reported value, excl. options
-
$386,922,438
-
Value change
-
+$50,585,288
-
Number of buys
-
19
-
Number of sells
-
12
-
Price
-
$0.9484
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q4 2020
As of 31 Dec 2020 SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 had 44 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $405,389,800 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Radcliffe Capital Management, L.P., CAMDEN ASSET MANAGEMENT L P /CA, JPMORGAN CHASE & CO, Opti Capital Management, LP, ADVENT CAPITAL MANAGEMENT /DE/, WOLVERINE ASSET MANAGEMENT LLC, Weiss Asset Management LP, OAKTREE CAPITAL MANAGEMENT LP, Invesco Ltd., and Polar Capital Holdings Plc.
This table shows 45 bond principal holders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.